Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Murakawa

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
British Journal of Anaesthesia|May 1, 1996
Sevoflurane, enflurane and isoflurane have no persistent postanaesthetic effects on the central nervous system in catsJ Kurata, T Adachi, S Nakao, et al.
Japanese Journal of Medicine|July 1, 1990
Danazol treatment for paroxysmal nocturnal hemoglobinuriaM Murakawa, T Shibuya, M Harada, et al.
The Journal of Biological Chemistry|July 21, 1998
Purification, molecular cloning, and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDaK K Lee, M Murakawa, S Takahashi, et al.
Oncogene|July 14, 1998
Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosisK K Lee, M Murakawa, E Nishida, et al.
Internal Medicine (Tokyo, Japan)|July 4, 1998
Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal diseaseH Tokushima, H Tamura, M Murakawa, et al.
Bone Marrow Transplantation|February 1, 1996
Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host diseaseT Miyamoto, K Akashi, S Hayashi, et al.
Acta Haematologica|January 1, 1992
Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatmentM Murakawa, T Okamura, K Tsutsumi, et al.
The Journal of Clinical Investigation|August 1, 1992
Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon IIIT Kamura, T Okamura, M Murakawa, et al.
Nihon Jinzo Gakkai Shi|August 1, 1996
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]H Tokushima, H Tamura, O Matsumura, et al.
Anesthesia and Analgesia|October 1, 1995
Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentrationT Adachi, T Shinomura, S Nakao, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Anaesthesia|May 1, 1996
Sevoflurane, enflurane and isoflurane have no persistent postanaesthetic effects on the central nervous system in catsJ Kurata, T Adachi, S Nakao, et al.
Japanese Journal of Medicine|July 1, 1990
Danazol treatment for paroxysmal nocturnal hemoglobinuriaM Murakawa, T Shibuya, M Harada, et al.
The Journal of Biological Chemistry|July 21, 1998
Purification, molecular cloning, and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDaK K Lee, M Murakawa, S Takahashi, et al.
Oncogene|July 14, 1998
Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosisK K Lee, M Murakawa, E Nishida, et al.
Internal Medicine (Tokyo, Japan)|July 4, 1998
Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal diseaseH Tokushima, H Tamura, M Murakawa, et al.
Bone Marrow Transplantation|February 1, 1996
Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host diseaseT Miyamoto, K Akashi, S Hayashi, et al.
Acta Haematologica|January 1, 1992
Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatmentM Murakawa, T Okamura, K Tsutsumi, et al.
The Journal of Clinical Investigation|August 1, 1992
Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon IIIT Kamura, T Okamura, M Murakawa, et al.
Nihon Jinzo Gakkai Shi|August 1, 1996
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]H Tokushima, H Tamura, O Matsumura, et al.
Anesthesia and Analgesia|October 1, 1995
Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentrationT Adachi, T Shinomura, S Nakao, et al.
Pageof 8